BDBM50010183 CHEMBL353203::[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3,11-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid

SMILES CC(=O)N[C@@H]1CSSC(C)(C)[C@H](C(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)CN(C)C(=O)[C@@H](CCCN=C(N)N)NC1=O

InChI Key InChIKey=CLKXDRBHAXGYTD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50010183   

TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50010183BDBM50010183(CHEMBL353203 | [16-Acetylamino-4-carbamoyl-13-(3-g...)
Affinity DataIC50: 7.34E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed